Atlas Trials

Study of Risk Factors and Genetic Association With Bortezomib-induced Peripheral Neuropathy in Multiple Myeloma

Clinical trial NCT03210753 · UNKNOWN

Trial details

NCT number
NCT03210753
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Multiple Myeloma
Start date
2016-12-01
Primary completion
2020-07-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.